Literature DB >> 16213525

Androgen receptor binding sites identified by a GREF_GATA model.

Katsuaki Masuda1, Thomas Werner, Shilpi Maheshwari, Matthias Frisch, Soyon Oh, Gyorgy Petrovics, Klaus May, Vasantha Srikantan, Shiv Srivastava, Albert Dobi.   

Abstract

Changes in transcriptional regulation can be permissive for tumor progression by allowing for selective growth advantage of tumor cells. Tumor suppressors can effectively inhibit this process. The PMEPA1 gene, a potent inhibitor of prostate cancer cell growth is an androgen-regulated gene. We addressed the question of whether or not androgen receptor can directly bind to specific PMEPA1 promoter upstream sequences. To test this hypothesis we extended in silico prediction of androgen receptor binding sites by a modeling approach and verified the actual binding by in vivo chromatin immunoprecipitation assay. Promoter upstream sequences of highly androgen-inducible genes were examined from microarray data of prostate cancer cells for transcription factor binding sites (TFBSs). Results were analyzed to formulate a model for the description of specific androgen receptor binding site context in these sequences. In silico analysis and subsequent experimental verification of the selected sequences suggested that a model that combined a GREF and a GATA TFBS was sufficient for predicting a class of functional androgen receptor binding sites. The GREF matrix family represents androgen receptor, glucocorticoid receptor and progesterone receptor binding sites and the GATA matrix family represents GATA binding protein 1-6 binding sites. We assessed the regulatory sequences of the PMEPA1 gene by comparing our model-based GREF_GATA predictions to weight matrix-based predictions. Androgen receptor binding to predicted promoter upstream sequences of the PMEPA1 gene was confirmed by chromatin immunoprecipitation assay. Our results suggested that androgen receptor binding to cognate elements was consistent with the GREF_GATA model. In contrast, using only single GREF weight matrices resulted in additional matches, apparently false positives. Our findings indicate that complex models based on datasets selected by biological function can be superior predictors as they recognize TFBSs in their functional context.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213525     DOI: 10.1016/j.jmb.2005.09.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Authors:  Madesh Belakavadi; Jason Saunders; Noah Weisleder; Preethi S Raghava; Joseph D Fondell
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

2.  Androgen-responsive gene database: integrated knowledge on androgen-responsive genes.

Authors:  Mei Jiang; Yunsheng Ma; Congcong Chen; Xuping Fu; Shu Yang; Xia Li; Guohua Yu; Yumin Mao; Yi Xie; Yao Li
Journal:  Mol Endocrinol       Date:  2009-09-17

3.  Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

Authors:  Myles C Hodgson; Long-jiang Shao; Anna Frolov; Rile Li; Leif E Peterson; Gustavo Ayala; Michael M Ittmann; Nancy L Weigel; Irina U Agoulnik
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

4.  2-(2-nitrobenzylidene) indolin-3-one compound inhibits transmembrane prostate androgen-induced protein (TMEPAI) expression and cancer cell proliferation.

Authors:  Yuyin Li; Jianjun Wang; Ning Song; Feihong Zeng; Miaomiao Zhao; Ali Wang; Yue Chen; Lei Jing; Peng Yu; Aipo Diao
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

5.  ERG oncogene modulates prostaglandin signaling in prostate cancer cells.

Authors:  Ahmed A Mohamed; Shyh-Han Tan; Chen Sun; Syed Shaheduzzaman; Ying Hu; Gyorgy Petrovics; Yongmei Chen; Isabell A Sesterhenn; Hua Li; Taduru Sreenath; David G McLeod; Albert Dobi; Shiv Srivastava
Journal:  Cancer Biol Ther       Date:  2011-02-15       Impact factor: 4.742

6.  A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.

Authors:  Ryan P McMullin; Albert Dobi; Laura N Mutton; András Orosz; Shilpi Maheshwari; Cooduvalli S Shashikant; Charles J Bieberich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

7.  Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.

Authors:  Irina U Agoulnik; William E Bingman; Manjula Nakka; Wei Li; Qianben Wang; X Shirley Liu; Myles Brown; Nancy L Weigel
Journal:  Mol Endocrinol       Date:  2008-09-11

8.  A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells.

Authors:  Hongyun Li; Linda L Xu; Katsuaki Masuda; Eliza Raymundo; David G McLeod; Albert Dobi; Shiv Srivastava
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

9.  GATA factors and androgen receptor collaborate to transcriptionally activate the Rhox5 homeobox gene in Sertoli cells.

Authors:  Anjana Bhardwaj; Manjeet K Rao; Ramneet Kaur; Miriam R Buttigieg; Miles F Wilkinson
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

10.  A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.

Authors:  Feng Jin; Joseph D Fondell
Journal:  Nucleic Acids Res       Date:  2009-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.